DARIOHEALTH CORP (DRIO) Fundamental Analysis & Valuation

NASDAQ:DRIO • US23725P3082

Current stock price

7.7 USD
-0.06 (-0.77%)
Last:

This DRIO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DRIO Profitability Analysis

1.1 Basic Checks

  • DRIO had negative earnings in the past year.
  • In the past year DRIO has reported a negative cash flow from operations.
  • DRIO had negative earnings in each of the past 5 years.
  • DRIO had a negative operating cash flow in each of the past 5 years.
DRIO Yearly Net Income VS EBIT VS OCF VS FCFDRIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • With a Return On Assets value of -31.52%, DRIO is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • DRIO has a Return On Equity of -49.53%. This is comparable to the rest of the industry: DRIO outperforms 45.71% of its industry peers.
Industry RankSector Rank
ROA -31.52%
ROE -49.53%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
DRIO Yearly ROA, ROE, ROICDRIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

  • DRIO's Gross Margin of 56.86% is in line compared to the rest of the industry. DRIO outperforms 48.57% of its industry peers.
  • In the last couple of years the Gross Margin of DRIO has grown nicely.
  • DRIO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
DRIO Yearly Profit, Operating, Gross MarginsDRIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. DRIO Health Analysis

2.1 Basic Checks

  • DRIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DRIO has more shares outstanding than it did 1 year ago.
  • DRIO has more shares outstanding than it did 5 years ago.
  • DRIO has a better debt/assets ratio than last year.
DRIO Yearly Shares OutstandingDRIO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
DRIO Yearly Total Debt VS Total AssetsDRIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -5.09, we must say that DRIO is in the distress zone and has some risk of bankruptcy.
  • DRIO's Altman-Z score of -5.09 is on the low side compared to the rest of the industry. DRIO is outperformed by 74.29% of its industry peers.
  • DRIO has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
  • DRIO has a Debt to Equity ratio of 0.41. This is in the lower half of the industry: DRIO underperforms 68.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z -5.09
ROIC/WACCN/A
WACC11.6%
DRIO Yearly LT Debt VS Equity VS FCFDRIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

  • DRIO has a Current Ratio of 4.55. This indicates that DRIO is financially healthy and has no problem in meeting its short term obligations.
  • DRIO has a better Current ratio (4.55) than 82.86% of its industry peers.
  • DRIO has a Quick Ratio of 4.02. This indicates that DRIO is financially healthy and has no problem in meeting its short term obligations.
  • DRIO's Quick ratio of 4.02 is amongst the best of the industry. DRIO outperforms 82.86% of its industry peers.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 4.02
DRIO Yearly Current Assets VS Current LiabilitesDRIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. DRIO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 74.56% over the past year.
  • The Revenue has been growing slightly by 7.29% in the past year.
  • DRIO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.03% yearly.
EPS 1Y (TTM)74.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%159.2%
Revenue 1Y (TTM)7.29%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%-32.55%

3.2 Future

  • DRIO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.89% yearly.
  • The Revenue is expected to grow by 9.37% on average over the next years. This is quite good.
EPS Next Y45.22%
EPS Next 2Y28.29%
EPS Next 3Y6.29%
EPS Next 5Y15.89%
Revenue Next Year-16.33%
Revenue Next 2Y1.82%
Revenue Next 3Y14.55%
Revenue Next 5Y9.37%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DRIO Yearly Revenue VS EstimatesDRIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
DRIO Yearly EPS VS EstimatesDRIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -200 -400 -600 -800

More info and screens

Find the best growth stocksShow best growing peers

0

4. DRIO Valuation Analysis

4.1 Price/Earnings Ratio

  • DRIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DRIO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRIO Price Earnings VS Forward Price EarningsDRIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRIO Per share dataDRIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.29%
EPS Next 3Y6.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DRIO Dividend Analysis

5.1 Amount

  • DRIO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DRIO Fundamentals: All Metrics, Ratios and Statistics

DARIOHEALTH CORP

NASDAQ:DRIO (3/25/2026, 8:22:18 PM)

7.7

-0.06 (-0.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-09
Earnings (Next)05-12
Inst Owners11.35%
Inst Owner Change1.67%
Ins Owners12.01%
Ins Owner Change0%
Market Cap52.05M
Revenue(TTM)24.73M
Net Income(TTM)-37.11M
Analysts82
Price Target18.36 (138.44%)
Short Float %0.97%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.8%
Min EPS beat(2)24.37%
Max EPS beat(2)159.22%
EPS beat(4)3
Avg EPS beat(4)59.87%
Min EPS beat(4)-17.64%
Max EPS beat(4)159.22%
EPS beat(8)7
Avg EPS beat(8)49.83%
EPS beat(12)9
Avg EPS beat(12)35%
EPS beat(16)11
Avg EPS beat(16)28.68%
Revenue beat(2)0
Avg Revenue beat(2)-18.56%
Min Revenue beat(2)-23.78%
Max Revenue beat(2)-13.34%
Revenue beat(4)1
Avg Revenue beat(4)-11.91%
Min Revenue beat(4)-23.78%
Max Revenue beat(4)0.92%
Revenue beat(8)1
Avg Revenue beat(8)-11.12%
Revenue beat(12)3
Avg Revenue beat(12)-10.13%
Revenue beat(16)5
Avg Revenue beat(16)-8.21%
PT rev (1m)0%
PT rev (3m)-1.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.85%
EPS NY rev (1m)74.96%
EPS NY rev (3m)74.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.24%
Revenue NY rev (1m)-6.22%
Revenue NY rev (3m)-6.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.1
P/FCF N/A
P/OCF N/A
P/B 0.69
P/tB 47.23
EV/EBITDA N/A
EPS(TTM)-5.24
EYN/A
EPS(NY)-4.39
Fwd EYN/A
FCF(TTM)-3.98
FCFYN/A
OCF(TTM)-3.96
OCFYN/A
SpS3.66
BVpS11.08
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.52%
ROE -49.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.86%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
F-Score5
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.89%
Cap/Sales 0.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 4.02
Altman-Z -5.09
F-Score5
WACC11.6%
ROIC/WACCN/A
Cap/Depr(3y)8.55%
Cap/Depr(5y)19.33%
Cap/Sales(3y)1.81%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%159.2%
EPS Next Y45.22%
EPS Next 2Y28.29%
EPS Next 3Y6.29%
EPS Next 5Y15.89%
Revenue 1Y (TTM)7.29%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%-32.55%
Revenue Next Year-16.33%
Revenue Next 2Y1.82%
Revenue Next 3Y14.55%
Revenue Next 5Y9.37%
EBIT growth 1Y33.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.05%
EBIT Next 3Y25.02%
EBIT Next 5Y16.13%
FCF growth 1Y14.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.57%
OCF growth 3YN/A
OCF growth 5YN/A

DARIOHEALTH CORP / DRIO Fundamental Analysis FAQ

What is the fundamental rating for DRIO stock?

ChartMill assigns a fundamental rating of 3 / 10 to DRIO.


Can you provide the valuation status for DARIOHEALTH CORP?

ChartMill assigns a valuation rating of 0 / 10 to DARIOHEALTH CORP (DRIO). This can be considered as Overvalued.


Can you provide the profitability details for DARIOHEALTH CORP?

DARIOHEALTH CORP (DRIO) has a profitability rating of 1 / 10.


How financially healthy is DARIOHEALTH CORP?

The financial health rating of DARIOHEALTH CORP (DRIO) is 4 / 10.